Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Clinical trial NCT04038619 · RECRUITING

Trial details

NCT number: NCT04038619
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colitis Diarrhea Malignant Genitourinary System Neoplasm Melanoma Lung Cancer Ovarian Cancer Uterine Cancer Breast Cancer Cervical Cancer

Start date: 2021-02-01
Primary completion: 2027-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.